Meta-analysis of 11 studies (2861 patients) with rheumatoid arthritis in stable remission: stopping biological DMARDs raised flare risk versus dose reduction or maintenance (RR 2.13, 95% CI 1.74–2.61); 87.5% regained control on re-treatment.
Meta-analysisn = 2,861
Lee et al. Risk of disease flare and clinical reversibility following discontinuation versus dose reduction of biological DMARDs in Rheumatoid arthritis: A systematic review and meta-analysis